Patents Assigned to DEUTSCHES KREBSFORSCHUNGSZENTRIUM - Justia Patents Search

Patents Assigned to DEUTSCHES KREBSFORSCHUNGSZENTRIUM

18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer

Patent number: 10016519

Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer.

Type: Grant

Filed: March 20, 2017

Date of Patent: July 10, 2018

Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRIUM, RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG

Inventors: Klaus Kopka, Martina Benesova, Jens Cardinale, Matthias Eder, Martin Schäfer, Ulrike Bauder-Wüst, Uwe Haberkorn, Michael Eisenhut